首页> 外国专利> The organophosphate indazoles derivatives and their use as Drugs with anticancer activity.

The organophosphate indazoles derivatives and their use as Drugs with anticancer activity.

机译:有机磷酸吲唑衍生物及其作为具有抗癌活性的药物的用途。

摘要

Organophosphorus Compounds, particularly of indazoles Derivatives, to compositions containing them, and their use as Drugs to treat cancers.Claim 1: a product of the General formula (1), in which: W represents a group selected from a Covalent Bond or a Covalent Bond; X represents a Group c = o, - - The NRA NRA -, - C = o,- (CH2) n -, - ch = CH - - - - - CSC, NRA, S, o, - - So, SO2, co, COO in which ra represents H or an alkyl group C1 - 4 may eventually form a cycle with R1, in which n = 0, 1, 2, 3, 4, 5, 67, 8, 9, 10, 11 or 12; r1 represents H (except when x = - SO2 -, - So -), alkyl, cycloalkyl, aryl, heteroaryl; in which R1 can be eventually replaced; R and R2, identical or different,Represent H or a selected Group among the radical alkyl, cycloalkyl, aryl, heteroaryl, heterocicloalquilo, Hydroxy, alkoxy and ariloxi,In which R and R2 are eventually replaced; and represents a Covalent Bond or a radical selected from: - The NRA - or - C = c = o, - - or -, - C = o) - (CH2) - SO2 -, N -,In which ra is selected from the group consisting of H, alkyl c1-4 alkyl, and R3 c1-4 joined to form a cycle; R3 is selected from the group consisting of H and (except where it is - - or - C = o,- SO2 -, or cycloalkyl) alkyl, aryl and heteroaryl; R3, R4 can be eventually replaced; R6 and R7, identical or different, Can independently Select between: H, halogenC1-4 alkyl, cyano, c1-4 alkoxy, RC (RB) - n, - n or - C = N - (RB) RC, RC (RB) - CO, in which RB and RC are selected independently from h, c1-4 alkyl,Cycloalkyl and C3 - 6; with the exception of the remains of Group of formula (2).
机译:权利要求1:通式(1)的产物,其中:W表示选自共价键或共价键的基团,有机磷化合物,特别是吲唑衍生物的有机磷化合物,以及含有它们的组合物。键; X代表组c = o,--NRA NRA-,-C = o,-(CH2)n-,-ch = CH-----CSC,N​​RA,S,o,--所以,SO2, co,其中ra代表H或C1-4烷基的COO最终可能与R1形成一个环,其中n = 0、1、2、3、4、5、67、8、9、10、11或12 ; r1表示H(x = -SO2-,-So-时除外),烷基,环烷基,芳基,杂芳基; R1最终可以被取代; R和R 2相同或不同,代表氢或选自烷基,环烷基,芳基,杂芳基,杂环烷基,羟基,烷氧基和芳基中的一个或多个基团,其中R和R2最终被取代;并且代表共价键或选自以下的基团:-NRA-或-C = c = o,--或-,-C = o)-(CH2)-SO2-,N-,其中ra选自由H,烷基的C 1-4烷基和R 3的C 1-4连接形成环的基团; R 3选自由H和(除非是-或-C = o,-SO 2-或环烷基的情况除外)烷基,芳基和杂芳基组成的组; R3,R4最终可以被替换; R6和R7,相同或不同,可独立选择:H,卤素C1-4烷基,氰基,c1-4烷氧基,RC(RB)-n,-n或-C = N-(RB)RC,RC(RB )-CO,其中RB和RC独立地选自h,c1-4烷基,环烷基和C3-6;除了公式(2)的组的其余部分。

著录项

  • 公开/公告号AR046736A1

    专利类型

  • 公开/公告日2005-12-21

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA S.A.;

    申请/专利号AR2004P104454

  • 发明设计人

    申请日2004-11-30

  • 分类号C07F9/40;A61P35/00;

  • 国家 AR

  • 入库时间 2022-08-21 21:40:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号